Analysis
I'd rather see a hardware company prove its manufacturing thesis with paying customers before it reaches public markets, and this week gave me a clean example of why, per Value Add Pulse's own IPO tracking: Gravitics is setting terms for a $125 million Nasdaq listing with zero disclosed revenue and a $24.5 million six-month net loss, reaching the public market through a reverse merger into an existing shell company rather than a traditional, fully marketed IPO.
A reverse merger isn't inherently a red flag -- it's a legitimate, faster path to a public listing that plenty of legitimate companies have used. But it's also a structure that specifically skips the extended roadshow and bookbuilding process that would otherwise force a company to defend its numbers against skeptical institutional investors before the stock starts trading. For a company with an actual revenue line and a track record, that speed tradeoff is a reasonable choice. For a company with $0 in six-month revenue asking public markets to underwrite its entire thesis on a single Axiom Space contract and a manufacturing roadmap, it's a way to reach Nasdaq with meaningfully less outside scrutiny than the number deserves.
What makes this week worth flagging specifically is the contrast sitting right next to it:
“A reverse merger isn't inherently a red flag -- it's a legitimate, faster path to a public listing that plenty of legitimate companies have used.”
- [Castelion](/pulse/castelion-13-billion-valuation-hypersonic-missiles-2026) -- raised $1B privately at a $13B valuation, roughly 26x its $500M in actual secured contracts
- [Lyntris](/pulse/lyntris-ipo-prices-17-50-below-range-2026) -- priced its own defense-tech IPO below its target range, just two days before Gravitics set terms
Three companies in the same sector, in the same week, landed at three very different points on the spectrum between private enthusiasm and public skepticism. That spread tells me the market hasn't actually agreed on how to price defense-and-space companies right now -- it's pricing each one on whatever structure and story it happens to arrive with, which is exactly the kind of inconsistency that produces mispriced deals in both directions.
None of this means Gravitics' underlying technology is bad or that its Axiom Space relationship isn't real. It means public market investors buying into this listing are inheriting execution risk -- on manufacturing, on regulatory approval, on whether the Axiom contract ever converts to recognized revenue at the scale implied -- that a standard IPO process would have forced Gravitics to defend more rigorously before pricing day.
Room for disagreement: a reverse merger is genuinely a more capital-efficient path to public markets for a company that needs growth capital now rather than in eighteen months after a full IPO process, and plenty of legitimate space and defense companies have used exactly this structure to reach Nasdaq faster without it later proving to be a problem. Investors who understand pre-revenue space infrastructure well enough to underwrite Gravitics' Axiom contract and manufacturing roadmap directly may be making a perfectly rational, eyes-open bet -- the structure itself isn't proof of a bad investment, only a signal that the diligence burden has shifted from the underwriters onto whoever actually buys the stock.
